NANOVIRICIDES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
NANOVIRICIDES, INC. (NNVC) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2020-06-30, per its 10-K filed 2021-10-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2021-10-12
- 2020-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2020-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2019-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.37M.
- 2019-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.22M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2020-06-30 | $0.00 10-K · filed 2021-10-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-06-22 | |
| 2019-12-31 | $1.37M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $1.22M 10-Q · filed 2019-11-15 | |
| 2019-06-30 | $0.00 10-K · filed 2021-10-12 | $1.65M 10-Q · filed 2019-11-15 |
| 2017-12-31 | $5.16M 10-Q · filed 2018-02-20 | |
| 2017-06-30 | $0.00 10-K · filed 2020-10-13 | |
| 2016-06-30 | $0.00 10-K · filed 2020-10-13 | |
| 2014-06-30 | $10.94M 10-K · filed 2015-02-23 | $5.70M 10-K · filed 2014-09-30 |
| 2013-06-30 | $3.75M 10-K · filed 2015-02-23 | |
| 2012-06-30 | $1.08M 10-K · filed 2015-02-23 | |
| 2011-06-30 | $17.52K 10-K · filed 2015-02-23 | |
| 2010-06-30 | $0.00 10-K/A · filed 2013-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |